These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 32999044)
1. A Combination of BRD4 and HDAC3 Inhibitors Synergistically Suppresses Glioma Stem Cell Growth by Blocking GLI1/IL6/STAT3 Signaling Axis. Wang Q; Jia S; Wang D; Chen X; Kalvakolanu DV; Zheng H; Wei X; Wen N; Liang H; Guo B; Zhang L Mol Cancer Ther; 2020 Dec; 19(12):2542-2553. PubMed ID: 32999044 [TBL] [Abstract][Full Text] [Related]
2. RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7. Liang H; Wang Q; Wang D; Zheng H; Kalvakolanu DV; Lu H; Wen N; Chen X; Xu L; Ren J; Guo B; Zhang L Biochem Pharmacol; 2020 Oct; 180():114118. PubMed ID: 32585142 [TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells. Yang L; Guo H; Dong L; Wang L; Liu C; Wang X Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314 [TBL] [Abstract][Full Text] [Related]
4. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway. Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920 [TBL] [Abstract][Full Text] [Related]
5. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Wang H; Lathia JD; Wu Q; Wang J; Li Z; Heddleston JM; Eyler CE; Elderbroom J; Gallagher J; Schuschu J; MacSwords J; Cao Y; McLendon RE; Wang XF; Hjelmeland AB; Rich JN Stem Cells; 2009 Oct; 27(10):2393-404. PubMed ID: 19658188 [TBL] [Abstract][Full Text] [Related]
6. Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway. Wen N; Guo B; Zheng H; Xu L; Liang H; Wang Q; Wang D; Chen X; Zhang S; Li Y; Zhang L Int J Oncol; 2019 Oct; 55(4):879-895. PubMed ID: 31485609 [TBL] [Abstract][Full Text] [Related]
7. HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway. Yang W; Liu Y; Gao R; Yu H; Sun T Cancer Lett; 2018 Feb; 415():164-176. PubMed ID: 29222038 [TBL] [Abstract][Full Text] [Related]
8. The SHH/Gli axis regulates CD90-mediated liver cancer stem cell function by activating the IL6/JAK2 pathway. Zhang K; Che S; Pan C; Su Z; Zheng S; Yang S; Zhang H; Li W; Wang W; Liu J J Cell Mol Med; 2018 Jul; 22(7):3679-3690. PubMed ID: 29722127 [TBL] [Abstract][Full Text] [Related]
10. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance. Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507 [TBL] [Abstract][Full Text] [Related]
11. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma. Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692 [TBL] [Abstract][Full Text] [Related]
12. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells. Tung B; Ma D; Wang S; Oyinlade O; Laterra J; Ying M; Lv SQ; Wei S; Xia S BMC Cancer; 2018 Oct; 18(1):1025. PubMed ID: 30348136 [TBL] [Abstract][Full Text] [Related]
13. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs). Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567 [TBL] [Abstract][Full Text] [Related]
14. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells. Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970 [TBL] [Abstract][Full Text] [Related]
15. Integrin α6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells. Herrmann A; Lahtz C; Song J; Aftabizadeh M; Cherryholmes GA; Xin H; Adamus T; Lee H; Grunert D; Armstrong B; Chu P; Brown C; Lim M; Forman S; Yu H Oncogene; 2020 Mar; 39(10):2156-2169. PubMed ID: 31819166 [TBL] [Abstract][Full Text] [Related]
17. BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo. Liu S; Li F; Pan L; Yang Z; Shu Y; Lv W; Dong P; Gong W Cancer Sci; 2019 Aug; 110(8):2493-2506. PubMed ID: 31215139 [TBL] [Abstract][Full Text] [Related]
18. Research progress of multi-target HDAC inhibitors blocking the BRD4-LIFR-JAK1-STAT3 signaling pathway in the treatment of cancer. Jia S; Jia Y; Liang S; Wu L Bioorg Med Chem; 2024 Aug; 110():117827. PubMed ID: 38964169 [TBL] [Abstract][Full Text] [Related]
19. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways. Chen J; Li N; Liu B; Ling J; Yang W; Pang X; Li T Life Sci; 2020 May; 248():117469. PubMed ID: 32109485 [TBL] [Abstract][Full Text] [Related]
20. Essential role of Gli proteins in glioblastoma multiforme. Santoni M; Burattini L; Nabissi M; Morelli MB; Berardi R; Santoni G; Cascinu S Curr Protein Pept Sci; 2013 Mar; 14(2):133-40. PubMed ID: 23544423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]